A Randomized, Double-Blind, Placebo Controlled Study Of Quetiapine SR (QTP) As Adjunctive Treatment In Mixed States (MS) Of Bipolar Disorder
Phase of Trial: Phase IV
Latest Information Update: 27 Mar 2017
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 28 Feb 2013 AstraZeneca added as trial company and lead trial centre as reported by ClinicalTrials.gov.
- 01 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Sep 2010 New trial record